Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML.

Evgeny Klyuchnikov Maximilian ChristopeitAnita BadbaranUlrike BacherUlrike Fritzsche-FriedlandUte-Marie von PeinChristine WolschkeNicolaus Kröger

Published in: European journal of haematology (2021)

Presence of detectable MRD was indicative for a high relapse risk, low LFS and OS. "Low" MRD level showed no significant impact on relapse, LFS and OS related to "high" MRD group.

Keyphrases

stem cell transplantation
flow cytometry
high dose
acute myeloid leukemia
free survival
bone marrow
low dose
allogeneic hematopoietic stem cell transplantation
acute lymphoblastic leukemia